NIO is an automotive company that designs and develops electric autonomous vehicles.
NIO, founded in November, 2014 and headquartered in Shanghai, is a company building electric smart car products. The founder is Li Bin. Listed on the NYSE on September 12, 2018, the company's major shareholders are NIO NEXTEV LIMITED. Rivals that have direct and indirect competition with NIO include Li Xiang, Xpeng Motors, Tesla, Waymo, etc.
Weilai automobile fell sharply at the beginning of the session and is now down 0.2%.
DFT: the subsidiary Ningfu new energy signed a joint venture agreement with Guangzhou Juwan
Yangdian Technology: Zhou Feng plans to reduce his shareholding by no more than 5.71%
South Africa's inflation rate reached 6.5%, breaking the target for the first time in five years.
Financing and Investment Activities in China's Mobility Industry From 2012 to 2022
Global Auto Chip Shortage: Challenges, Opportunities and Implications for OEMs
CITIC Securities: it is estimated that the sales of new energy vehicles in June will reach 543-553 thousand
Ruihu mold: the aluminum alloy lightweight body mold of Jihu alpha s model with automatic driving technology provided by Huawei is manufactured by the company
Transformation and acceleration several auto companies stated that they would stop producing fuel vehicles
Beyond technology: it is planned to issue no more than 450million yuan of convertible bonds
Macquarie gave velai's H shares an initial rating of outperformance, with a target price of HK $215.
Li Bin, CEO of Weilai: 800V battery pack will be launched in 2024, which supports power change and ultra fast charging
Everbright Securities: there is no other major information that should be disclosed but has not been disclosed
Zhongchuang environmental protection: Jiangxi Naihua environmental protection obtained the hazardous waste operation license
Wei Lai, Li Bin: it is expected that the gross profit margin will rebound from the third quarter
Overseas Chinese funds must reach a new high in consumption and investment, with more than half of them over allocated to Moutai, Guizhou
Aoxiang pharmaceutical: Shugeng sodium gluconate API passed CDE technical review